KDventures ABKDEVF 30 Current Ratio is 16.98 as of Mar. 2026, which is 91% above its 10-year median of 8.91. GuruFocus rates KDEVF with a GF Score™ of 30/100 and a GF Value™ of $0.67. The stock has 3 warning signs investors should review. Among 1,412 Biotechnology companies, KDventures AB ranks better than 89.02% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. KDventures AB's current ratio for the quarter that ended in Mar. 2026 was 16.98.
KDventures AB has a current ratio of 16.98. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for KDventures AB's Current Ratio or its related term are showing as below:
KDEVF'
s Current Ratio Range Over the Past 10 Years
Min: 0.17 Med: 8.91 Max: 40.06
Current: 16.98
During the past 13 years, KDventures AB's highest Current Ratio was 40.06. The lowest was 0.17. And the median was 8.91.
KDEVF's Current Ratio is ranked better than 89.02% of 1412
companies
in the Biotechnology industry
Industry Median: 3.89
vs KDEVF: 16.98
KDventures AB (OTCPK:KDEVF) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
KDventures AB Current Ratio Related Terms
KDventures AB Current Ratio Historical Data
* Premium members only.
The historical data trend for KDventures AB's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDEVF vs VRTX, REGN, ALNY: Current Ratio Comparison
For the Biotechnology subindustry, KDventures AB's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KDventures AB Current Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, KDventures AB's Current Ratio distribution charts can be found below:
* The bar in red indicates where KDventures AB's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KDventures AB (KDEVF) has a Current Ratio of 16.98 as of Mar. 2026. This is 91% above median its historical median of 8.91. Over the past decade, KDventures AB's Current Ratio has ranged from 0.17 to 40.06. According to the industry distribution chart, KDventures AB ranks #155 out of 1412 companies in the Biotechnology industry, placing it in the top 11%.
Is KDventures AB's Current Ratio too high?
KDventures AB's current Current Ratio of 16.98 is 91% above median its 10-year median of 8.91. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 40.06. The Biotechnology industry median Current Ratio is 3.89. KDventures AB's value of 16.98 is 336.5% above this industry median. Based on the distribution chart, KDventures AB ranks #155 out of 1412 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, KDventures AB has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does KDventures AB's Current Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, KDventures AB ranks #155 out of 1412 companies for Current Ratio. This places KDventures AB in the top 11% of its industry — outperforming the majority of peers. The industry median Current Ratio is 3.89. KDventures AB's value of 16.98 is 336.5% above this benchmark. Historically, KDventures AB's own Current Ratio has ranged from 0.17 to 40.06 over the past decade. While the company's 10-year median is 8.91 vs. the industry median of 3.89, KDventures AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Biotechnology company?
The median Current Ratio among Biotechnology companies is 3.89, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KDventures AB's current Current Ratio of 16.98 is 336.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Biotechnology industry, the median Current Ratio is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KDventures AB's current Current Ratio is 16.98, which is 91% above median its own 10-year median of 8.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KDventures AB stock overvalued right now?
KDventures AB (KDEVF) has a current Current Ratio of 16.98. The stock's GF Value™ is $0.67, compared to a current price of $0.26 — trading 61.6% below its estimated fair value. The current Current Ratio is 16.98, which is 91% above median its 10-year median of 8.91 and 336.5% above the Biotechnology industry median of 3.89. KDventures AB's overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For KDventures AB (KDEVF), the current Current Ratio is 16.98 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KDventures AB (KDEVF) Overvalued in 2026?
Based on GuruFocus' analysis, KDventures AB stock appears to be undervalued.
The current stock price of $0.26 is trading 61.6% below its estimated GF Value™ of $0.67.
Key valuation signals for KDEVF:
Current Ratio: 16.98 (91% above median its 10-year median of 8.91)
GF Value™: $0.67 vs. price of $0.26 (61.6% below fair value)
Industry Position: 336.5% above the Biotechnology median (#155 of 1412)
No single metric tells the full story. See the KDEVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KDventures AB is a Nordic investment company specialized in life sciences. The company identifies and invests in pharmaceutical projects and medical technology products originating from research institutions in the Nordic region. Through a diversified portfolio across various stages of development, professional due diligence, and active board engagement, the company creates value from early research to commercialization. The company offers investors exposure to both listed and private life science projects with value growth potential.
30GF Score
Get the complete analysis for KDEVF
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KDEVF has been successfully added to your 
